{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-005077","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2021-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.597781+00:00","generated_at":"2026-06-28T02:47:21.102092+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Biodesix appoints Dr. Jon Faiz Kayyem to board of directors effective December 6, 2021","bullets":["Dr. Kayyem brings 20+ years experience in molecular diagnostics, having founded GenMark Diagnostics and Clinical Micro Sensors.","Initial equity grant of $375,000: 50,368 NQSOs (5-year vest) and 31,619 RSUs (1-year vest).","Prorated annual grant of $87,397: 27,038 NQSOs vesting March 31, 2022, strike at close on December 7, 2021.","Appointed to Compensation Committee effective December 7, 2021; term expires at 2024 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-005077","json":"https://secwatch.observer/filing/0000950170-21-005077.json","markdown":"https://secwatch.observer/filing/0000950170-21-005077.md","text":"https://secwatch.observer/filing/0000950170-21-005077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/0000950170-21-005077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/bdsx-20211206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:47:21.102092+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6911680512","claim":"Dr. Jon Faiz Kayyem was appointed as director at BIODESIX INC.","evidence_excerpt":"On December 6, 2021, Dr. Jon Faiz Kayyem was appointed to the Board of Directors of Biodesix, Inc. (the “Company”), effective December 6, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017021005077/0000950170-21-005077-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}